methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
Published October 25, 2017 · Recall initiated: September 25, 2017
Summary
FDA records drug Class II recall D-0012-2018, published October 25, 2017 and initiated September 25, 2017. Recalling firm: RXQ Compounding LLC; Status: Terminated; Reported quantity: 945 vials; Lot: Lot: 04252017@1, exp 5/9/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- RXQ Compounding LLC
- Distributor
- TX, LA, PA, MA, FL, and OH
- Lot
- Lot: 04252017@1, exp 5/9/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVITAMIN B COMPLEX 100 (MDV), 30 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.August 14, 2019
- FDAMORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9,August 14, 2019
- FDATRAVASOL 10% (AMINO ACID) INJECTION SOLUTION, 50 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9,August 14, 2019
- FDAGLUTATHIONE 200MG/ML (MDV) INJECTION SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9,August 14, 2019
- FDASymbio Muc Eye, 0.17 fl.oz. 5mL bottles, Manufactured for and distributed in the US b: Biological Health GroupOctober 25, 2017
- FDAAlprazolam Tablets, USP, 0.25 mg, 100-count Unit Dose tablets per carton, Rx Only, Manufactured by: WatsonOctober 25, 2017
Questions about this recall
Was methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10 recalled?
Yes. FDA published recall D-0012-2018 on October 25, 2017. Reported hazard: Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone